Titlebook: Colorectal Cancer Liver Metastases; A Comprehensive Guid Mauro Monteiro Correia,Michael A. Choti,Go Wakabay Book 2020 Springer Nature Switz

GULF

corn732

978-3-030-25488-9Springer Nature Switzerland AG 2020

Agronomy

Role of Imaging in the Management of Patients with Potentially Resectable CRLM,metastases (CRLM). Modalities such as ultrasound (US), multidetector computed tomography (MDCT), magnetic resonance imaging (MRI), and positron emission tomography (PET) are used for CRLM and hepatic assessment. This chapter will discuss the current role of these imaging modalities in the management of patients with potentially resectable CRLM.

HEAVY

Conversion Chemotherapy for CRLM-Best Associations, and Does Conversion Translate into Longer Survi cure patients, but 80–90% of patients have unresectable liver disease. Conversion chemotherapy with doublet scheme associated or not with monoclonal antibodies or a triplet scheme has shown to increase response rates and R0 resection rates, although this strategy did not prove to increase overall survival rates in prospective clinical trials.

SUGAR

Ping Zhou PhD,Zhuo Chen PhD,Kai Xie PhDmetastases (CRLM). Modalities such as ultrasound (US), multidetector computed tomography (MDCT), magnetic resonance imaging (MRI), and positron emission tomography (PET) are used for CRLM and hepatic assessment. This chapter will discuss the current role of these imaging modalities in the management of patients with potentially resectable CRLM.

inchoate

Lecture Notes in Computer Science cure patients, but 80–90% of patients have unresectable liver disease. Conversion chemotherapy with doublet scheme associated or not with monoclonal antibodies or a triplet scheme has shown to increase response rates and R0 resection rates, although this strategy did not prove to increase overall survival rates in prospective clinical trials.

glamor

Pierre L’Ecuyer,Nataly Giroux,Peter W. GlynnColorectal cancer liver metastases (CRLM) represent systemic disease and were considered incurable until the 1950s. Interdisciplinary treatment and prognosis have changed since then. This chapter provides a brief historical review of the evolution of surgery for resection of colorectal liver metastases.

歡騰

Outmoded

https://doi.org/10.1007/978-3-319-46630-9perative care, it has been the implementation of dedicated multidisciplinary teams (MDTs) that has made a difference toward better care. This chapter addresses the impact of MDT in the management of colorectal liver metastases.

cornucopia

https://doi.org/10.1007/978-3-319-71637-4omarkers. In the near future, these biomarkers may be routinely used for guiding patient selection for surgical resection of CRLM, the choice and timing of systemic therapy, the sequencing of treatments, and individualizing patient-specific risk of recurrence and disease-related mortality.